2024 Summer Conference | C4 - Models of Infection as a Trigger for Autoimmunity
Program Materials Program Evaluations
| 01:00 PM - 01:27 PM EDT | Speaker |
Post-infectious Neurological Autoimmunity in the Clinic
Thais Armangue, MD |
| 01:27 PM - 01:54 PM EDT | Speaker |
Experimental Models of Post-infectious CNS Neurological Autoimmunity
Marianna Spatola, MD, PhD |
| 01:54 PM - 02:21 PM EDT | Speaker |
Virus-like Capsids That Trigger Paraneoplastic Neurological Symptoms
Jason Shepherd, PhD |
| 02:21 PM - 02:28 PM EDT | Abstract |
051 - Powassan Virus Encephalitis in Pediatric Patients: A Case Series
Celia Greenlaw, MD |
| 02:28 PM - 02:35 PM EDT | Abstract |
055 - FACE DROP: A Clinical Risk Assessment Tool to Differentiate Acute Lyme Disease Facial Palsy From Bell’s Palsy
Caleb R. McEntire, MD |
| Marianna Spatola, MD, PhD | The institution of Dr. Spatola has received research support from Spanish National Health Institute (Carlos III), FIS grant. The institution of Dr. Spatola has received research support from Spanish National Institute of Health - Miguel Servet Grant. The institution of Dr. Spatola has received research support from La Caixa Foundation. |
| Jason Shepherd, PhD | No disclosure on file |
| Thais Armangue, MD | Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Armangue has received research support from ISCIII(Spanish institute of health) -PI21/00316, Marato TV3, La Caixa Research Foundadion, Pablove Foundation (689368), Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP. |
| Maarten J. Titulaer, MD, PhD | The institution of Dr. Titulaer has received research support from Dutch Epilepsy Foundations (NEF 19-08). The institution of Dr. Titulaer has received research support from CSL Behring. The institution of Dr. Titulaer has received research support from UCB. The institution of Dr. Titulaer has received research support from Netherlands Organisation for Scientific Research (ZonMW, Memorabel initiative and E-RARE UltraAIE) . The institution of Dr. Titulaer has received research support from Horizon Therapeutics / Amgen. The institution of Dr. Titulaer has received research support from Dioraphte (charity). The institution of Dr. Titulaer has received research support from Guidepoint Global LLC. The institution of Dr. Titulaer has received research support from ArgenX. Dr. Titulaer has received publishing royalties from a publication relating to health care. |
| Alexander J. Gill, MD, PhD | Dr. Gill has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medical Logix, LLC. Dr. Gill has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Health Union, LLC . Dr. Gill has received research support from National Multiple Sclerosis Society. |
| Celia Greenlaw, MD | Dr. Greenlaw has nothing to disclose. |
| Rebecca MacRae, MD | Dr. MacRae has nothing to disclose. |
| Margaret M. Wilson-Murphy, MD | Dr. Wilson-Murphy has nothing to disclose. |
| Caleb R. McEntire, MD | Dr. McEntire has nothing to disclose. |
| Sun Young Chung | Ms. Chung has nothing to disclose. |
| Brian Chang, MD, PhD | Dr. Chang has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for MicroPort. Dr. Chang has received intellectual property interests from a discovery or technology relating to health care. |
| Keisha Barrera | Ms. Barrera has nothing to disclose. |
| Nathan Jowett | No disclosure on file |
| Bart Chwalisz, MD | Dr. Chwalisz has nothing to disclose. |
| Yan Zhao | No disclosure on file |
| Gary Wormser | No disclosure on file |